DXCM Q4 2025 Earnings — DexCom, Inc. Revenue & Financial Results | Market Cap Arena

DXCMDexCom, Inc.

$27B

Q4 2025 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$1.3B+13.1% YoY

Gross Profit

$793M62.9% margin

Operating Income

$323M25.6% margin

Net Income

$267M21.2% margin

EPS (Diluted)

$0.67

QoQ Revenue Growth

+4.2%

Cash Flow

Operating Cash Flow

$294M

Free Cash Flow

$192M

Stock-Based Comp.

$35M

Balance Sheet

Total Assets

$6.3B

Total Liabilities

$3.6B

Stockholders' Equity

$2.7B

Cash & Equivalents

$918M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.3B	$1.1B	+13.1%
Gross Profit	$793M	$656M	+20.9%
Operating Income	$323M	$189M	+71.0%
Net Income	$267M	$152M	+76.2%

Geographic Segments

Non-US

$368M100%